scholarly article | Q13442814 |
P50 | author | Andrea C. Villanti | Q48248015 |
Jennifer Tidey | Q60055546 | ||
Cecilia L Bergeria | Q89571914 | ||
John R Hughes | Q89571916 | ||
P2093 | author name string | Stacey C Sigmon | |
Sarah H Heil | |||
Maxine L Stitzer | |||
Stephen T Higgins | |||
Diann E Gaalema | |||
Danielle R Davis | |||
Jeffrey Priest | |||
Joanna M Streck | |||
P2860 | cites work | Are Pharmacotherapies Ineffective in Opioid-Dependent Smokers? Reflections on the Scientific Literature and Future Directions | Q26801047 |
Nicotine withdrawal in U.S. smokers with current mood, anxiety, alcohol use, and substance use disorders | Q33716576 | ||
Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence | Q34029147 | ||
Smoking and mental illness in the U.S. population | Q34362758 | ||
Randomized Trial of Reduced-Nicotine Standards for Cigarettes. | Q34496332 | ||
Intolerance for withdrawal discomfort and motivation predict voucher-based smoking treatment outcomes for smokers with substance use disorders | Q35007655 | ||
Assessment and treatment of comorbid psychiatric disorders in opioid-dependent patients | Q35024272 | ||
Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation. | Q36047601 | ||
Effects of abstinence from tobacco: etiology, animal models, epidemiology, and significance: a subjective review | Q36762000 | ||
Cigarette smoking, socioeconomic status, and psychosocial factors: examining a conceptual framework | Q36841943 | ||
Reduced nicotine content cigarettes and nicotine patch | Q36927046 | ||
Measurement of socioeconomic status in health disparities research. | Q36959114 | ||
An international systematic review of smoking prevalence in addiction treatment | Q37187104 | ||
Inter-relationships between conditioned and primary reinforcement in the maintenance of cigarette smoking | Q37206730 | ||
Socioeconomic status and smoking: a review | Q37957179 | ||
Psychiatric Disorders Among Patients Seeking Treatment for Co-Occurring Chronic Pain and Opioid Use Disorder. | Q38385795 | ||
Addiction Potential of Cigarettes With Reduced Nicotine Content in Populations With Psychiatric Disorders and Other Vulnerabilities to Tobacco Addiction | Q38612443 | ||
Current Cigarette Smoking Among Adults - United States, 2005-2015. | Q39198854 | ||
Smoking and mental illness: A population-based prevalence study | Q39513259 | ||
Predictors of nicotine withdrawal symptoms: findings from the first randomized smoking cessation trial in a low-income country setting | Q39847521 | ||
Changes in Substance Abuse Treatment Use Among Individuals With Opioid Use Disorders in the United States, 2004-2013. | Q40437665 | ||
Errors in using tobacco withdrawal scale | Q42746927 | ||
Interest in smoking cessation among injection drug users | Q43667218 | ||
Current cigarette smoking among adults - United States, 2005-2012. | Q45386693 | ||
Methadone-nicotine interactions in methadone maintenance treatment patients. | Q46013631 | ||
Establishing a nicotine threshold for addiction. The implications for tobacco regulation | Q46058830 | ||
Development and validation of an Overall Anxiety Severity And Impairment Scale (OASIS). | Q46100865 | ||
Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette | Q46897472 | ||
Signs and symptoms of tobacco withdrawal | Q49016637 | ||
Tobacco Withdrawal Among Opioid-Dependent Smokers | Q49495854 | ||
The early time course of smoking withdrawal effects. | Q50935985 | ||
Cigarette smoking and subjective response: Effects of d-amphetamine | Q52271040 | ||
A Nicotine-Focused Framework for Public Health. | Q53553970 | ||
Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults | Q53847483 | ||
Treating Cigarette Smoking in Methadone Maintenance Clients | Q67815481 | ||
Buprenorphine effects on cigarette smoking | Q69962071 | ||
Effects of methadone on human cigarette smoking and subjective ratings | Q71362184 | ||
Interim buprenorphine treatment during delays to comprehensive treatment: Changes in psychiatric symptoms | Q89231006 | ||
Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees | Q91057652 | ||
Smokers with opioid use disorder may have worse drug use outcomes after varenicline than nicotine replacement | Q92349081 | ||
P921 | main subject | opioid use disorder | Q1639178 |
substance use disorder | Q7632070 | ||
P577 | publication date | 2020-02-06 | |
P1433 | published in | Experimental and Clinical Psychopharmacology | Q15716319 |
P1476 | title | Investigating tobacco withdrawal in response to reduced nicotine cigarettes among smokers with opioid use disorder and other vulnerabilities |
Search more.